Shah, Vatsal <br/><br/>
Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2013 
 - 6193-204 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-1536  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--biosynthesis<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Ascitic Fluid--cytology<br/>Biological Transport<br/>Dendrimers--pharmacology<br/>Female<br/>Gene Expression<br/>Gonadotropin-Releasing Hormone--analogs & derivatives<br/>Humans<br/>Hyaluronan Receptors--biosynthesis<br/>Mice<br/>Mice, Nude<br/>Nanomedicine<br/>Nanoparticles--chemistry<br/>Neoplasm Invasiveness<br/>Neoplasm Transplantation<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Pilot Projects<br/>Polypropylenes<br/>RNA Interference<br/>RNA, Small Interfering--administration & dosage<br/>Receptors, LHRH--biosynthesis<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured